IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q2 2019 Holdings

Filed 2019-08-14 | 13 holdings | $22.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$14.8M557,45565.8%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$7.4M737,52933.0%
Ishares TR(IBB)PutNASDAQ BIOTECH464287556$109.1K1,000,0000.5%
Spdr Series Trust(XBI)PutS&P BIOTECH78464A870$43.9K500,0000.2%
Uniqure NV(QURE)SHSN90064101$28.5K364,5960.1%
Merus N VCOMN5749R100$20.4K1,391,4970.1%
Spero Therapeutics Inc(SPRO)COM84833T103$13.3K1,154,3560.1%
Fate Therapeutics Inc(FATE)COM31189P102$12.2K602,0960.1%
Synlogic IncCOM87166L100$9.5K1,043,9220.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$9.4K951,5270.0%
Pieris Pharmaceuticals IncCOM720795103$6.8K1,451,8500.0%
Proqr Thrapeutics N VSHS EURON71542109$6.8K748,8610.0%
Galapagos NV(GLPG)SPON ADR36315X101$6.0K46,8400.0%